Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 54 Breast Neoplasms 43 Neoplasms 4 Salivary Gland Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostate Adenocarcinoma 2 Advanced Breast Cancer 2 Recurrence 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Inflammatory Breast Neoplasms 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Sensitive Prostate Cancer 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 HER2 Negative Breast Cancer 1 Fallopian Tube Neoplasms 1 Castrate Sensitive Prostate Cancer 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × Goserelin × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡